Clinical Trial Update: Bomedemstat and Maintenance Immunotherapy for Treatment of Newly Diagnosed Extensive Stage Small Cell Lung Cancer [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on bomedemstat with maintenance immunotherapy in newly diagnosed extensive-stage or limited-stage small cell lung cancer (NCT05191797); th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extensive-stage Small Cell Lung Cancer
• Limited-stage Small Cell Lung Cancer

Drugs mentioned

• Bomedemstat (bomedemstat)

Snippet

Sponsor: University of Washington | Conditions: Extensive Stage Lung Small Cell Carcinoma, Limited Stage Lung Small Cell Carcinoma | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2024-09-26